comparemela.com
Home
Live Updates
Patent Lawsuits - Breaking News
Pages:
3
4
5
6
7
8
9
Latest Breaking News On - Patent lawsuits - Page 2 : comparemela.com
Apple Scores Win in AliveCor Legal Battle With USPTO Invalidating Several Patents
The United States Patent and Trademark Office's Patent Trial and Appeal Board today invalidated a trio of AliveCor patents that AliveCor used in.
United states
Trademark office patent trial
International trade commission
United states patent
Trademark office
Patent trial
Appeal board
Apple watch
Macrumors apple
Patent lawsuits
Apple Accuses AliveCor of Brazen Patent Infringement in New Countersuit
Apple today filed a patent infringement lawsuit against AliveCor, a company that has developed the ECG "KardiaBand" designed for the Apple.
Alivecor kardiamobile
International trade commission
Apple watch
Kardiamobile card
Apple lawsuits
Patent lawsuits
Astellas, BeiGene, Serum Institute—Fierce Pharma Asia
Astellas takes gene therapy hit. Novartis and BeiGene post PD-1 win. Serum Institute halts COVID vaccine production.
Fierce pharma asia
Cell amp gene therapy
Pd 1 l1
Uchenne muscular dystrophy dmd
Serum institute of india
Covid 19
Vaccine manufacturing
Patent lawsuits
Wuxi apptec
Fierce pharma homepage
Fierce Pharma Asia—Eisai s reduced Aduhelm role; Chinese biotechs US delisting risks; Zai Lab s new COO from Lilly
Eisai has decided to exit its supporting role for Biogen's Alzheimer's drug Aduhelm. Chinese companies including several biotechs face potential U.S.
Fierce pharma asia
Securities and exchange commission
Zai lab
Eli lilly
Omen 039s health
Ultomiris ravulizumab cwvz
Patent lawsuits
Covid 19
Plant expansion
Drug recall
Stevanato group
Fierce pharma homepage
AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year
Alvotech, the Icelandic holdout battling AbbVie in court over its Humira biosimilar, has reached an accord with the U.S. pharma giant.
Boehringer ingelheim
Patent lawsuits
Trade secrets
Fierce pharma homepage
vimarsana © 2020. All Rights Reserved.